KYTX
Price
$5.73
Change
-$0.11 (-1.88%)
Updated
Oct 22 closing price
Capitalization
354.36M
20 days until earnings call
Intraday BUY SELL Signals
ZVRA
Price
$10.33
Change
-$0.03 (-0.29%)
Updated
Oct 22 closing price
Capitalization
613.43M
12 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KYTX vs ZVRA

KYTX vs ZVRA Comparison Chart in %
View a ticker or compare two or three
VS
KYTX vs. ZVRA commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYTX is a StrongBuy and ZVRA is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for KYTX with price predictions
Oct 22, 2026

KYTX's Stochastic Oscillator stoops into oversold zone

The Stochastic Oscillator for KYTX moved into oversold territory on October 22, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where KYTX's RSI Oscillator exited the oversold zone, 17 of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.

The Moving Average Convergence Divergence (MACD) for KYTX just turned positive on October 20, 2026. Looking at past instances where KYTX's MACD turned positive, the stock continued to rise in 20 of 24 cases over the following month. The odds of a continued upward trend are 83%.

Following a +6.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where KYTX advanced for three days, in 121 of 135 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

KYTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KYTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

The Aroon Indicator for KYTX entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 19 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. KYTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.141) is normal, around the industry mean (2.973). P/E Ratio (-1.962) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KYTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for ZVRA with price predictions
Oct 22, 2026

ZVRA sees MACD Histogram just turned negative

ZVRA saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 14, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 50 instances where the indicator turned negative. In 41 of the 50 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ZVRA as a result. In 75 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.

ZVRA moved below its 50-day moving average on September 22, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ZVRA crossed bearishly below the 50-day moving average on September 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 75%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZVRA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

The Aroon Indicator for ZVRA entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ZVRA's RSI Oscillator exited the oversold zone, 23 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 67 cases where ZVRA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

Following a +5.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZVRA advanced for three days, in 230 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

ZVRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 29 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. ZVRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 86 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZVRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.818) is normal, around the industry mean (2.973). P/E Ratio (10.760) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (10.667) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (5.176) is also within normal values, averaging (438.009).

FUNDAMENTALS RATINGS
ZVRA: Fundamental Ratings
ZVRA
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
86
SMR RATING
1..100
29
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYTXZVRA
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
75%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (KYTX: $5.84 vs. ZVRA: $10.33)
Brand notoriety: KYTX and ZVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYTX: 98% vs. ZVRA: 65%
Market capitalization -- KYTX: $354.36M vs. ZVRA: $613.43M
KYTX [@Biotechnology] is valued at $354.36M. ZVRA’s [@Biotechnology] market capitalization is $613.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYTX’s FA Score shows that 1 FA rating(s) are green while ZVRA’s FA Score has 1 green FA rating(s).

  • KYTX’s FA Score: 1 green, 4 red.
  • ZVRA’s FA Score: 1 green, 4 red.
According to our system of comparison, ZVRA is a better buy in the long-term than KYTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYTX’s TA Score shows that 5 TA indicator(s) are bullish while ZVRA’s TA Score has 4 bullish TA indicator(s).

  • KYTX’s TA Score: 5 bullish, 2 bearish.
  • ZVRA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, KYTX is a better buy in the short-term than ZVRA.

Price Growth

KYTX (@Biotechnology) experienced а +2.73% price change this week, while ZVRA (@Biotechnology) price change was +0.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.

Reported Earning Dates

KYTX is expected to report earnings on Nov 11, 2026.

ZVRA is expected to report earnings on Nov 03, 2026.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
KYTX
Daily Signal:
Gain/Loss:
ZVRA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

KYTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYTX has been loosely correlated with FDMT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if KYTX jumps, then FDMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYTX
1D Price
Change %
KYTX100%
-1.88%
FDMT - KYTX
60%
Loosely correlated
-6.10%
IMNM - KYTX
58%
Loosely correlated
+1.44%
VYGR - KYTX
49%
Loosely correlated
-7.92%
KURA - KYTX
49%
Loosely correlated
-0.20%
EDIT - KYTX
48%
Loosely correlated
-0.80%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RSPS31.951.11
+3.58%
Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS)
FLRT46.20-0.21
-0.45%
Pacer Aristotle Pacific Floating Rate High Income ETF (FLRT)
SPY763.96-9.13
-1.18%
State Street SPDR S&P 500 ETF (SPY)
TEXN33.38-0.57
-1.68%
iShares Texas Equity ETF (TEXN)
AVNV82.50-1.44
-1.71%
Avantis All International Markets Value ETF (AVNV)